Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,753.50
Bid: 1,753.50
Ask: 1,754.00
Change: 20.00 (1.15%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,754.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

Tue, 22nd Apr 2014 06:33

LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said a group of executives including Chief Executive Officer Andrew Witty acquired shares and American Depositary Shares under the company performance share plan at a price of 1581.50 pence per share and USD52.55 per ADS Wednesday.

Details are as follows.

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

19,564.837

 

Dr M M Slaoui

 

5,637.905

Mr S Dingemans

8,217.586

 

Mr S M Bicknell

1,325.959

 

Mr R G Connor

2,687.452

 

Mrs D P Connelly

 

2,344.551

Mr J Ford

 

303.243

Mr S A Hussain

6,666.166

 

Mr W C Louv

 

1,653.860

Mr D S Redfern

2,829.821

 

Ms C Thomas

3,905.590

 

Mr P C Thomson

1,905.093

 

Mr D E Troy

 

3,350.705

Dr P J T Vallance

8,136.668

 

Ms E Walmsley

4,729.965

 

Mrs V A Whyte

541.530

 


The company also said, a group of executives bought ADSs at USD52.0208 each April 10, which are detailed below.

Director/PDMR

 

 

 

Number of ADSs

 

Connected Person

 

Number of ADSs

 

Dr M M Slaoui

 

 

1,788.686

 

Dr K Slaoui

 

20.762

 

Mrs D P Connelly

 

895.847

 

-

 

-

 

Mr J Ford

 

34.235

 

-

 

-

 

Mr W C Louv

 

301.078

 

-

 

-

 

Mr D E Troy

 

 

825.851



The company further said Deidre Connelly and Bill Louv, both divisional executives acquired ADSs at USD53.007 each details are outlined below.

Mrs D P Connelly

Acquisition of 45.263 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 33.354 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

Acquisition of 33.140 ADSs under the personal contribution element of the Plan.


Glaxo shares closed at 1,550.12 pence dowb 13.38p Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.